These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1815480)

  • 21. Hydroxypropyl chitosan bearing beta-cyclodextrin cavities: synthesis and slow release of its inclusion complex with a model hydrophobic drug.
    Prabaharan M; Mano JF
    Macromol Biosci; 2005 Oct; 5(10):965-73. PubMed ID: 16208630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxypropyl-beta-cyclodextrin increases aqueous solubility and stability of anandamide.
    Jarho P; Urtti A; Järvinen K; Pate DW; Järvinen T
    Life Sci; 1996; 58(10):PL 181-5. PubMed ID: 8602110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lumichrome complexation by cyclodextrins: influence of pharmaceutical excipients.
    Lilletvedt M; Kristensen S; Tønnesen HH
    Pharmazie; 2010 Dec; 65(12):871-6. PubMed ID: 21284255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen.
    Nikumbh KV; Sevankar SG; Patil MP
    Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxypropyl-β-Cyclodextrin and β-Cyclodextrin as Tablet Fillers for Direct Compression.
    Conceição J; Adeoye O; Cabral-Marques HM; Sousa Lobo JM
    AAPS PharmSciTech; 2018 Aug; 19(6):2710-2718. PubMed ID: 29978292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supersaturating drug delivery systems: effect of hydrophilic cyclodextrins and other excipients on the formation and stabilization of supersaturated drug solutions.
    Brewster ME; Vandecruys R; Verreck G; Peeters J
    Pharmazie; 2008 Mar; 63(3):217-20. PubMed ID: 18444510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronobiological and chronopharmacological studies of ketoprofen and its solid dispersion form using adjuvant arthritis model in rats.
    Solankar AK; Jagtap AG
    Indian J Exp Biol; 2005 Jan; 43(1):46-52. PubMed ID: 15691065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aerosolization potential of cyclodextrins--influence of the operating conditions.
    Le VN; Leterme P; Gayot A; Flament MP
    PDA J Pharm Sci Technol; 2006; 60(5):314-22. PubMed ID: 17089700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chondroitin sulfate-based anti-inflammatory macromolecular prodrugs.
    Peng YS; Lin SC; Huang SJ; Wang YM; Lin YJ; Wang LF; Chen JS
    Eur J Pharm Sci; 2006 Sep; 29(1):60-9. PubMed ID: 16831535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects and toxicity of new fomocaine derivatives and of 2-hydroxypropyl-beta-cyclodextrin inclusion compounds in rats.
    Fleck C; Wennek-Klose J; Wange J; Oelschläger H
    Arzneimittelforschung; 2004; 54(5):265-74. PubMed ID: 15212188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The evaluation of ketoprofen pharmaceutical availability in the presence of a dry extract from goldenrod (Solidago virgaurea L.) of synthetic polymer vehicles].
    Berner-Strzelczyk A; Kołodziejska J; Piechota-Urbańska M; Zgoda MM
    Polim Med; 2009; 39(4):39-44. PubMed ID: 20099734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery.
    Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
    Int J Pharm; 2005 Jul; 298(1):55-67. PubMed ID: 15941634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of the preparation method on the physical-chemical properties of ketoprofen-cyclodextrin-phosphatidylcholine ternary systems.
    Cirri M; Maestrelli F; Mennini N; Mura P
    J Pharm Biomed Anal; 2009 Dec; 50(5):690-4. PubMed ID: 19097721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rofecoxib-beta-cyclodextrin inclusion complex for solubility enhancement.
    Rawat S; Jain SK
    Pharmazie; 2003 Sep; 58(9):639-41. PubMed ID: 14531460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of hydroxypropyl-beta-cyclodextrin on hydrocortisone dissolution from films intended for ocular drug delivery.
    Bećirević-Laćan M; Filipović-Grcić J
    Pharmazie; 2000 Jul; 55(7):518-20. PubMed ID: 10944780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interaction of charged and uncharged drugs with neutral (HP-beta-CD) and anionically charged (SBE7-beta-CD) beta-cyclodextrins.
    Okimoto K; Rajewski RA; Uekama K; Jona JA; Stella VJ
    Pharm Res; 1996 Feb; 13(2):256-64. PubMed ID: 8932446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxypropylcyclodextrins in parenteral use. I: Lipid dissolution and effects on lipid transfers in vitro.
    Irie T; Fukunaga K; Pitha J
    J Pharm Sci; 1992 Jun; 81(6):521-3. PubMed ID: 1522487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerated ketoprofen release from spray-dried polymeric particles: importance of phase transitions and excipient distribution.
    Gue E; Muschert S; Willart JF; Danede F; Delcourt-Debruyne E; Descamps M; Siepmann J
    Drug Dev Ind Pharm; 2015 May; 41(5):838-50. PubMed ID: 24766587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism.
    Wahab A; Khan GM; Akhlaq M; Khan NR; Hussain A; Khan MF; Khan H
    Pharmazie; 2011 Sep; 66(9):677-83. PubMed ID: 22026123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular State of Active Pharmaceutical Ingredients in Ketoprofen Dermal Patches Characterized by Pharmaceutical Evaluation.
    Azuma M; Fujii M; Inoue M; Hisada H; Koide T; Kemper M; Yamamoto Y; Suzuki N; Suzuki T; Fukami T
    Biol Pharm Bull; 2018; 41(9):1348-1354. PubMed ID: 30175772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.